Baebies' Series B - III Round

Baebies raised a round of funding on February 06, 2018. Investors include Illumina Ventures.

Baebies developed a nimble bioassay automation platform to rapidly perform multiplex enzymatic assays and other tests. The company licensed its core technology, digital microfluidics, from Illumina. I…

Articles about Baebies' Series B - III Round: